HFA European Congress Set to Unveil Key Fitness Industry Data and GLP-1 Exercise Findings
The 2026 HFA European Congress, scheduled for September 24–26 at London Stadium, will feature exclusive research including the 2026 HFA Global Report and the industry's largest global retention study. New findings on the interaction between GLP-1 medications and exercise will also be presented. The event aims to shape the future of fitness through these insights.
The September gathering at London Stadium will present the 2026 Global Report covering over 30 commercial markets, alongside a preview of the forthcoming Global Retention Benchmark Report. New data concerning GLP-1 medications and exercise will also be shared, with the event co-hosted by ukactive and EVOLVE's founder.
Keynotes feature Keepme.ai's CEO discussing AI-driven gym operations and Olympic champion Alistair Brownlee on organizational adaptability. Additional programming includes a Women's Networking Summit, guided club tours, and panels with healthcare bodies like the Royal College of General Practitioners.
The release of GLP-1 exercise data could significantly alter how fitness operators design programs for patients on these medications, potentially bridging clinical care and gym settings. Retention benchmarks may help clubs reduce member churn, while AI insights could shift workforce priorities toward member interaction. Society may benefit from more integrated health pathways, though access to these advanced services could remain uneven across socioeconomic groups.